Change in HbA1c With Biphasic Insulin Aspart 70/30 in Two Different Treatment Regiments in Subjects With Type 2 Diabetes Inadequately Controlled With Oral Anti-Diabetic Drug Therapy.
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 20 May 2009 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 05 Sep 2007 Status changed from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History